ISB News

ISB Post Doc Gets Patent for Protein that Blocks HIV

MartinShelton
Martin Shelton

Martin Shelton, a post doc in the Lee Hood lab, just received his first patent. He shared the following explanation with his 10-year-old nephew who’s a burgeoning scientist/inventor/engineer.

“We made a small molecule called a peptide (which is a sciency word for a piece of a protein). This peptide blocks a function that is key to the spread of the Human Immunodeficiency Virus (HIV, the virus that causes AIDS) within a person by trapping the virus within the infected cell and preventing it from infecting surrounding cells. It knocks out a similar function in cancer that could hinder tumor growth and the spread of cancer from one part of the body to another. We think it could one day be used to help treat HIV/AIDS or cancer, but it still has a long way to go and would have to pass many, many more tests before it could be used as a medicine. But in the meantime, it’s a useful tool for studying certain aspects of these diseases.”

Congratulations, Martin!

20130502-184513.jpg

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.